CML is characterized by the BCR::ABL1 fusion gene, which is formed by a genetic translocation between chromosome 9 and chromosome 22 (Rinke et al., 2020). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.